article thumbnail

Should Startups Announce Their Funding?

Both Sides of the Table

One of the advantages of blogging, using social media, public speaking, etc as a VC is that you get a more nuanced view of these shifts by watching your own successes and failures. Journalists don’t often write stories that talk about, “This cool new company I met at a conference.” ” Why? Funding is news.

Startup 355
article thumbnail

6 Keys To Growing Your Career Through The Gig Economy

Startup Professionals Musings

Take advantage of any and all current opportunities, such as industry conferences and special projects, to increase your intellectual capital for current roles and gigs in the future. Every employee or entrepreneur needs to build a competitive reputation on the Internet, through a website, blog, LinkedIn profile, and social media.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

A Post Startup Execs Should Forward to Your Spouse or Partner. 12 Tips for Making it Work

Both Sides of the Table

Anyway, as I winnowed my way through the comments section of my blog post on relationships I realized my own wife has posted a response! ” That way you aren’t hitting him up on an important topic when he might be stressed out about company layoffs, fund raising or some other major stress at work.

Tips 418
article thumbnail

Bio Roundup: Theranos Cuts, Alnylam Stops, Nobel Eats Its Own & More

Xconomy

The firm will now focus on its miniLab, which CEO Elizabeth Holmes touted as a follow-on version of its Edison test system at a scientific conference in August. —Merrimack Pharmaceuticals (NASDAQ: MACK ) announced layoffs of 22 percent of its staff and the resignation of CEO Robert Mulroy. CLINICAL NEWS.

article thumbnail

Biotech Roundup: Kadmon Debt, Hemo Data, Loose Lips & More

Xconomy

Data from a hematology conference stoked dreams of approval, though still on a far horizon, for a couple drug makers. Familiar biotech names—not necessarily familiar for the right reasons—made news this week in biotech. Long anticipated, Walgreens officially cut ties with Theranos , and the FDA both gave and denied approvals.

News 55
article thumbnail

Biotech Roundup: Hellos, Goodbyes, “Cures” Delays And Trial News

Xconomy

All eyes are on Holmes, who is scheduled to present data from the company’s technology at a medical conference on August 1. Layoffs will hit two New Jersey sites and one in Pennsylvania, resulting in a loss of less than 10 percent of its “discovery, preclinical and early development” staff, a spokeswoman said via e-mail.

News 40